Thomas Van Stappen

Leuven, VLG, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Burden of illness of Duchenne muscular dystrophy in Belgium: A retrospective, descriptive, cross-sectional study.

Burden of illness of Duchenne muscular dystrophy in Belgium: A retrospective, descriptive, cross-sectional study.

Journal: Journal of neuromuscular diseases

Published: March 14, 2026

Anti-infliximab antibodies: How to compare old and new data?

Anti-infliximab antibodies: How to compare old and new data?

Journal: Journal of pharmaceutical and biomedical analysis

Published: July 10, 2019

Influence of early adalimumab serum levels on immunogenicity and long-term outcome of anti-TNF naive Crohn's disease patients: the usefulness of rapid testing.

Influence of early adalimumab serum levels on immunogenicity and long-term outcome of anti-TNF naive Crohn's disease patients: the usefulness of rapid testing.

Journal: Alimentary pharmacology & therapeutics

Published: May 22, 2018

Anti-infliximab antibody concentrations can guide treatment intensification in patients with Crohn's disease who lose clinical response.

Anti-infliximab antibody concentrations can guide treatment intensification in patients with Crohn's disease who lose clinical response.

Journal: Alimentary pharmacology & therapeutics

Published: July 25, 2017

Current Practice for Therapeutic Drug Monitoring of Biopharmaceuticals in Inflammatory Bowel Disease.

Current Practice for Therapeutic Drug Monitoring of Biopharmaceuticals in Inflammatory Bowel Disease.

Journal: Therapeutic drug monitoring

Published: March 23, 2017

Clinical relevance of detecting anti-infliximab antibodies with a drug-tolerant assay: post hoc analysis of the TAXIT trial.

Clinical relevance of detecting anti-infliximab antibodies with a drug-tolerant assay: post hoc analysis of the TAXIT trial.

Journal: Gut

Published: October 04, 2016

Rapid Test for Infliximab Drug Concentration Allows Immediate Dose Adaptation.

Rapid Test for Infliximab Drug Concentration Allows Immediate Dose Adaptation.

Journal: Clinical and translational gastroenterology

Published: June 22, 2016

Comparisons of Serum Infliximab and Antibodies-to-Infliximab Tests Used in Inflammatory Bowel Disease Clinical Trials of Remicade®.

Comparisons of Serum Infliximab and Antibodies-to-Infliximab Tests Used in Inflammatory Bowel Disease Clinical Trials of Remicade®.

Journal: The AAPS journal

Published: May 03, 2016

Harmonization of Infliximab and Anti-Infliximab Assays Facilitates the Comparison Between Originators and Biosimilars in Clinical Samples.

Harmonization of Infliximab and Anti-Infliximab Assays Facilitates the Comparison Between Originators and Biosimilars in Clinical Samples.

Journal: Inflammatory bowel diseases

Published: March 09, 2016

Validation of a sample pretreatment protocol to convert a drug-sensitive into a drug-tolerant anti-infliximab antibody immunoassay.

Validation of a sample pretreatment protocol to convert a drug-sensitive into a drug-tolerant anti-infliximab antibody immunoassay.

Journal: Drug testing and analysis

Published: December 10, 2015

Fiber optic-SPR platform for fast and sensitive infliximab detection in serum of inflammatory bowel disease patients.

Fiber optic-SPR platform for fast and sensitive infliximab detection in serum of inflammatory bowel disease patients.

Journal: Biosensors & bioelectronics

Published: October 28, 2015

Variability in Golimumab Exposure: A 'Real-Life' Observational Study in Active Ulcerative Colitis.

Variability in Golimumab Exposure: A 'Real-Life' Observational Study in Active Ulcerative Colitis.

Journal: Journal of Crohn's & colitis

Published: October 05, 2015

Showing 1-12 of 18

Last Updated: 09/26/2026